← Sanofi
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Goodwill | $40.3b | $40.3b | $44.2b | $44.5b | $44.4b | $48.1b | $49.9b | $49.4b | $43.4b | $41.3b | |
| Intangible Assets Other Than Goodwill | $10.9b | $13.1b | $21.9b | $16.6b | $18.4b | $21.4b | $21.6b | $24.3b | $22.6b | $26.3b | |
| Additional Financial Items | |||||||||||
| Current Tax Assets Current | — | — | — | — | $1.2b | $612.0m | $374.0m | $391.0m | $724.0m | $397.0m | |
| Current Tax Liabilities Current | $1.1b | $1.2b | $733.0m | $613.0m | $604.0m | $309.0m | $574.0m | $597.0m | $697.0m | $751.0m | |
| Deferred Tax Assets | $4.7b | $4.3b | $4.6b | $5.4b | $4.2b | $4.6b | $5.4b | $6.4b | $8.0b | $8.6b | |
| Issued Capital | — | $2.5b | $2.5b | $2.5b | $2.5b | $2.5b | $2.5b | $2.5b | — | $2.4b | |
| Unused Tax Losses For Which No Deferred Tax Asset Recognised | $431.0m | $287.0m | $310.0m | $317.0m | $331.0m | $875.0m | $1.1b | $1.2b | $2.0b | $1.6b | |
| Total Assets | $104.7b | $99.8b | $111.4b | $112.7b | $114.5b | $120.2b | $126.7b | $126.5b | $132.8b | $126.8b | |
| Deferred Tax Liabilities | $2.3b | $1.6b | $3.4b | $2.3b | $1.8b | $1.6b | $1.8b | $1.9b | $2.2b | $1.7b | |
| Deferred Tax Liability Asset | $2.4b | $2.7b | $1.2b | ($3.1b) | ($2.4b) | ($3.0b) | ($3.5b) | ($4.6b) | ($5.8b) | ($6.9b) | |
| Noncontrolling Interests | $170.0m | $169.0m | $159.0m | $174.0m | $146.0m | $350.0m | $368.0m | $313.0m | $350.0m | $334.0m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.